ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

NCI to Host SBIR Investor Forum

November 7, 2014

In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI

September 13, 1985

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

NCI-Approved Clinical Trials

May 28, 2004